Member Info for CHELSEA7

my thoughts with you and yours Rubal, keep punching. ATVB

Would like to hear from you, hope treatment is still going well. ATVB

As described by Wikepedia.............................

""Non-executive director
From Wikipedia, the free encyclopedia
Jump to navigationJump to search
A non-executive director (abbreviated to non-exec, NED or NXD) independent director or external director is a member of the board of directors of a company or organisation who does not form part of the executive management team. They are not employees of the company or affiliated with it in any other way and are differentiated from inside directors, who are members of the board who also serve or previously served as executive managers of the company (most often as corporate officers). However they do have the same legal duties, responsibilities and potential liabilities as their executive counterparts.[1][2][3]

Non-executive directors provide independent oversight and serve on committees concerned with sensitive issues such as the pay of the executive directors and other senior managers; they are usually paid a fee for their services but are not regarded as employees.[4]

All directors should be capable of seeing company and business issues in a broad perspective. Nonetheless, non-executive directors are usually chosen because of their independence and initiatives, and are of an appropriate caliber and have particular personal qualities.""

Sometimes i still forget how easy it is to look up anything, regardless of what we think we know.

Just my opinion to a few very negative takes, i feel it is one for the conspiracy theorists, and glad ratty posted his thoughts. It certainly will be interesting to see who/if anybody is lined up to replace her, I could understand somebody else with more of an understanding perhaps to the territory we are moving into.

Still surprises me, even in our own sector, what news can drive a share substantially. We seem to go red nearly everytime we have news. How low can we go? seems a pretty relevant question after our two latest RNSs, i cannot answer that, but IMHO i am surprised we fell more, particularly on the agreement with Karolinska.

So relieved the temperatures have dropped significantly the last few days, i have slept for twenty odd hours a day the past couple of weeks. Pretty sure it hasn"t been that great for anybody either.

Hoping , after the latest dip, to see some blue here this week, neither news IMO deserved a negative SP, and yes an interesting appointment would be seen as that. Take care all.

It most certainly would be.

Thanks rats. Yeah i was just happy to see that RNS, Karolinska has been very much on my mind. If not earth shattering SP news at first sight, it can only be positive, as is the company that is surrounding us in general. From little acorns.................!!

It takes time for a small company like us as we are accepting, I have never doubted what is being developed, just nice to see others seeing something special in it too. Fully understand the impatience as i do those building stakes here, for that i am very grateful to the SP, in building mine.

Don"t think I will ever fully understand this market, the only bad i think was the SCIB1 vaccine, but we fall again on news. Just glad for the holding i have really, managed to get my average down to just under 19p, which considering i came in at 41p and a few between 30/35 is no mean feat. Would be happy with SP if i was still adding, hoping others see value here.

One day Ratty.................I hope!! Goodnight.

Afternoon Guys,

Agree with the first four lines Balerno, although harsh. Been funny for me wanting news for weeks, then missing two days running of RNSs.

Yes delighted with the Karolinska Institute agreement, suggests to me they have indeed found something in Moditope worth pursuing. Yesterdays news, really dont know, I guess one for the conspiracy views. I posted something recently about a fund raising with one of Calculas VCTs, not sure any relevance to this.

As Ruck posted does the agreement make it more or less likely for a commercial deal, would just like to add the possibility of winning Grand Challenge to that. Does it really matter where a large funding to develop Moditope comes from??

Well done those who topped up in the low 11s, the ask was always coming back to 12 anyway. Will we drift?? Well i think that agreement speaks volumes for our potential, lets face it we hit 64p on potential, surely six years on and making good contacts, with two SCIB trials coming up, that potential is even greater??

As i also said last week, happy to hold, i worry less about Scancell than i do the AIM market in general. Looking forward to more news, perhaps, before the AGM in maybe eight weeks time and that Karolinska RNS can only make us feel more confident in the Grand Challenge IMHO.

As ever some will buy, some sell or hold, I think we are better placed than at any time previously.

Have a good weekend guys, still very hopeful my 120k will make a difference to me, that thought and hope certainly keeps me fighting and the distinct hope our treatments make the difference for the many afflicted by cancer.

ATVB.

Board Ch

angehttps://www.investegate.co.uk/scancell-hlds--sclp-/rns/board-change/201808100700044045X/.................................

Balerno, re exosomes.............................

https://www.nature.com/articles/aps201817

https://www.nature.com/articles/aps201817

Plenty of information accessable, hope that helps.

Well done you guys who traded this well. Good to see PIs make some money in this crazy market.

Well they certainly have found something. This part of the RNS augers wellfor Moditopes potential and the Grand Challenge IMHO........................

""This collaboration builds on the previous agreement, announced on 11 March 2016, which allowed the parties to explore how immunity to citrullinated proteins is involved in the control of tumour growth for the development of cancer vaccines.  Broadening this agreement will allow further investigation into the potential of Moditope® for any cancer immunotherapy, including, T-Cell Receptor based therapeutics.""

Goodnight you guys.

Thought this well overpriced at 1.30 with any good news pretty much priced in, except for exceptional news.

Admire those who trade successfully on AIM, you can almost imagine the next news on AST. Think this will bounce back as it has today, only for the very brave IMHO. I would of unhappily averaged down as i did on three previous trades here. It got me out of trouble each time....................just!!!

GL you guys.

Todays RNS does make you think of the buys in recent days, especially the 256k buy the other day. Again not suggesting anything, but it does make you think. ATB

Thanks for your post. Funny been waiting for news and i have just woken up. Was certainly on my mind and very pleased after two years studies are moving on.

I think Ruck Rovers post spoke largely how i felt on this news, except it is something i have been feeling if we win Grand Challenge, i am sure Ruck and a few here have too................................

False dawn, no one here is expecting a cash deal to come from the Karolinska institute.

What you need to ask is does this news

Make a cash deal more or less likely?
Make a deal more or less valuable?
Make a deal come sooner or later?.................................

I think for me, given 24 hours sleeps are becoming the norm, a spell in hospital might be on, I am not in pain, and rather hoping the recent weeks of excessive heat in London has taken its toll on me.

Because i highlight Rucks post i do not think he says anything but the obvious, to bear in mind, whatever i am happy with that agreement it highlights positive findings with Moditope and speaks volumes about our chances in Grand Challenge, at the end of the day i would welcome any monies we receive to take our Science forward.

Wish you guys all well, the potential still screams out.

Cheers Ivy, glad someone appreciates it.

Back to my hospital grind shortly, three biopsies lined up and not at all well. Taking a break from LSE, it has felt like walking on egg shells posting here the last few weeks. will be good to get news soon and read some input from others

Take care guys ATVB.

https://www.terrapinn.com/template/live/go/9885/19970?utm_campaign=9885_Vaccines%20West%20Coast_NEWSLETTER%201&utm_medium=email&utm_source=Eloqua&evtuEID=9885.0000&evtuID=CTRHD000010123160

Another interesting conference, Genentech presenting amongst a very impressive list........................

Following an incredibly successful inaugural year, the World Vaccine & Immunotherapy Congress is back in San Diego from November 28 – 30 to bring you the latest developments in the world of vaccines and immunotherapy from some of the best and biggest names in the industry.

Don’t take my word for it, download the agenda now and see for yourself!

I am thrilled to announce the plenary keynote speakers (total 150+ speakers) this year:

Dr Richard Pan
State Senator
6th District, California

Dr Peter Hotez President of the Sabin Vaccine Institute & Dean of National School of Tropical Medicine
Baylor College of Medicine

Robb Butler
Former Program Manager, Vaccine-preventable Diseases and Immunization
World Health Organization

Dr David Gorski Professor & Chief, Breast Surgery Section
Wayne State University School of Medicine

Dr Eve Dubé
Researcher, Quebec National Institute of Public Health; Invited professor, Department of Anthropology
Université Laval

Dr Janelle Ayres Associate Professor, Nomis Center for Immunobiology & Microbial Pathogenesis
Salk Institute for Biological Studies

Dr Nancy Valente
Vice President, Global Product Development, Hematology/OncologyHead Hematology Development
Genentech

Dr Ho Cho
VP Biotherapeutics Executive Research
Celgene

Dr Ezra Cohen Professor of Medicine, UC San Diego Moores Cancer Center, Co-Director San Diego Center for Precision Immunotherapy

Dr Travis Young Director, Protein Sciences
California Institute for Biomedical Research

Dr Min Song
Program Director, Cancer Therapy Evaluation Program, Cancer Moonshot Implementation Team National Cancer Institute, NCI

Dr Theresa LaVallee Head of Translational Medicine
Parker Institute for Cancer Immunotherapy

Dr Catherine L. Higgins, Director of Scientific Program Management
Stand Up to Cancer

Dr John Baldoni
Senior Vice President, DPU Head, ln Silico Discovery
GSK Pharmaceuticals

Dr Larry Smarr, Director
California Institute for Telecommunications and Information Technology

Dr Sergei Gleyzer Research Associate, Department of Physics, University of Florida; Coordinator of the LHC Machine-Learning Working Group
CERN
DOWNLOAD THE AGENDA NOW

And so it finished. The 12.00 trade looks like a bed and ISA IMHO.

Was very lucky not to be in GWMO today, I very rarely trade but have three times there, always averaging down for a total single figure loss!! It gave me more headaches than Scancell ever has. The grass always looks greener...........

Buys 32k........1 trade

Sells 31k 8 trades

Open up 11.8p on the bid

Well of course it has Klue Loss. Companies dont just go under overnight, there should be stricter rules for Insolvent Trading and Directors responsibility for doing so. Amazes me how rarely we do see action taken, it costs money to prosecute and without reasonable chance of recovery it just doesn"t go that far. It is the insolvency laws that need tightening, or should i say enforced.